Browse > Article

Antidiabetic Activity of IH-901 in db/db Mice  

Choi, Yun-Suk (Pharmacology and Clinical Pharmacy Lab., College of Pharmacy, Kyung Hee University)
Han, Gi-Cheol (Pharmacology and Clinical Pharmacy Lab., College of Pharmacy, Kyung Hee University)
Han, Eun-Jung (Pharmacology and Clinical Pharmacy Lab., College of Pharmacy, Kyung Hee University)
Park, Keum-Joo (Pharmacology and Clinical Pharmacy Lab., College of Pharmacy, Kyung Hee University)
Park, Jong-Suk (Pharmacology and Clinical Pharmacy Lab., College of Pharmacy, Kyung Hee University)
Sung, Jong-Hwan (ILHWA Co. LTD. Central Research Center)
Chung, Sung-Hyun (Pharmacology and Clinical Pharmacy Lab., College of Pharmacy, Kyung Hee University)
Publication Information
YAKHAK HOEJI / v.50, no.6, 2006 , pp. 345-350 More about this Journal
Abstract
The pharmacological properties of ginseng are mainly attributed to ginsenosides, the active constituents that are found in the extracts of different species of ginseng. Lately; the studies on ginsenosides are mainly focused on IH-901, a major intestinal bacterial metabolite of ginsenosides. In this study; we examined the anti-diabetic activity of IH-901 in C57BU61 db/db mice model. IH-901 was administrated orally at a dose of 20 mg/kg for 5 weeks. During the experimental period, body weight and blood glucose levels were measured every week. After 5 weeks, db/db mice were sacrificed and diabetic parameters were analyzed. IH-901 treated group showed a significant decrease in fasting blood glucose levels (from 10.5 mM to 9.4 mM), insulin resistance index (from 163.6 to 100.2) and triglyceride levels (from 115.3 to 70.1) compared to the diabetic control. In Pancreatic islets morphology; IH-901 treated group revealed much less infltrated mononuclear cells, indicating that IH-901 recovered ${\beta}$-cell damage due to hyperglycemia. In addition, IH-901 upregulated expressions of glucose transporter 4 (GLUT4) and PPAR-${\gamma}$ in skeletal muscle and adipose tissue, respectively. Taken together IH-901might be a potential anti-hyperglycemic agent with insulin sensitizing effect.
Keywords
ginsenosides; IH-901; anti-diabetic activity; db/db mice; glucose transporter (GLUT4); PPAR-${\gamma}$;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Attele, A. S., Zhou, Y. P., Xie, J. T., Wu, J. A., Zhang, L., Dey, L., Pugh, W., Rue, P. A., Polonsky, K. S. and Yuan, C. S. : Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51, 1851 (2002)   DOI   ScienceOn
2 Hasegawa, H., Sung, J. H., Matsumiya, S. and Uchiyama, M. : Metabolism of Ginseng saponin by human intestinal bacteria, and isolation and identification of the bacteria associated with the metabolism. J. Trad. Med. 14, 396 (1997)
3 Lee, B. H., Lee, S. J., Hui, J. H., Lee, S. Y., Sung, J. H., Hui, J. D. and Moon, C. K. : In vitro antigenotoxic of novel Ginseng saponin metabolites formed by intestinal bacteria. Planta Med. 64, 500 (1998)   DOI   ScienceOn
4 Suda, K., Murakami, K., Murata, J., Hasegawa, H. and Saiki, I. : An intestinal bacterial metabolite (M1) of ginseng protopanaxadiol saponin inhibits tumor-induced neovascularization. J. Trad. Med. 17, 144 (2000)
5 Tai, E. S., Lim, S. D., Tan, B. Y., Chew, S. K., Heng, D. and Tan, C. E. : Screening for diabetes mellitus: a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications. Diabet Med. 17, 771 (2000)   DOI   ScienceOn
6 Rosen, E. D. and Spiegelman, B. M. : $PPAR{\gamma}$: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276, 37731 (2001)   DOI
7 Hasegawa, H., Sung, J. H., Matsumiya, S. and Uchiyama, M. : Pharmacodynamic analysis of Ginseng saponin metabolites formed by human intestinal bacteria. J. Trad. Med. 14, 394 (1997)
8 Trinder, P. : Determination of blood glucose using an oxidaseperoxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 22, 158 (1969)   DOI
9 Diabetes Control and Complications Trial Research Group : The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977 (1993)   DOI   ScienceOn
10 Vuksan, V. and Sievenpiper J. L. : Herbal remedies in the management of diabetes: Lessons learned from the study of ginseng. Nutr. Metab. Cardiovasc. Dis. 15, 149 (2005)   DOI   ScienceOn
11 Lee, S. J., Ko, W. G., Kim, J. H., Sung J. H., Lee, S. J., Moon, C. K. and Lee, B. H. : Induction of apoptosis by a novel intestinal metabolite of Ginseng saponin via cytochrome c-mediated activation of caspase-3 protease. Biochem. Pharmacol. 60, 677 (2000)   DOI   ScienceOn
12 Hasegawa, H., Sung, J. H. and Huh, J. D. : Ginseng intestinal bacterial metabolite IH-901 as a new anti-metastatic agent. Arch. Pharm. Res. 20, 539 (1997)   DOI   ScienceOn
13 Korea national statical office : The cause of death statics. (2004)
14 Anoja, S., Wu, J. A. and Yuan, C. S. : Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol. 58, 1685 (1999)   DOI   ScienceOn
15 Yokozawa, Kobayashi, T., Oura, H. and Kawashima, Y. : Studies on the mechanism of the hypoglycemic activity of ginsenosides-Rb2 in streptozotocin-diabetic rats. Chem. Pharm. Bull. 33, 869 (1985)   DOI   ScienceOn
16 Ge, K., Guermah, M., Yuan, C. X., Ito, M. Wallberg, A. E., Spiegelman, B. M. and Roeder, R. G. : Transcription coactivator TRAP220 is required for $PPAR{\gamma}2$-stimulated adipogenesis. Nature 417, 563 (2002)   DOI
17 Cavaghan, M. A., Ehrmann, D. A. and Polonsky, K. S. : Interaction between insulin resistance and insulin secretion in the development of glucose intolerance. J. Clin. Invest. 106, 329 (2000)   DOI   ScienceOn
18 Joo, C. N. and Kim, J. H. : Study on the hypoglycemic action of ginseng saponin on streptozotocin induced diabetic rats (1) Korean J. Ginseng Sci. 16(3), 190 (1992)
19 Chomczynski, P. and Sacchi, N. : Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162(1), 156 (1987)
20 Kimura, M., Waki, L., Chujo, T., Kikuchi, T., Hiyama, C., Yamazaki, K. and Tanaka, O. : Effects of hypoglycemic components in Ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas. J. Pharmacobiodyn. 4(6), 410 (1981)   DOI
21 Davies, G. F., Khandelwal, R. L., Wu, L., Juurlink, B. H. and Roesler W. J. : Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-${\gamma}$ ($PPAR{\gamma}$)- independent, antioxidant-related mechanism. Biochem. Pharmacol. 62(8), 1071 (2001)   DOI   ScienceOn
22 Ko, S. K., Sung, J. H., Choi, Y. E., Lee, C. R., Park, K. S. and Chung, S. H. : Comparisons of antidiabetic activities between white ginseng ethanol extract and IH-901 in steptozotocininduced diabetic rats. Yakhak Hoeji 47(1), 52 (2003)
23 Barthel, A. and Schmoll, D. : Novel concepts in insulin regulation of hepatic gluconeogenesis. Am. J. Physiol. Endocrinol. Metab. 285(4), E685 (2003)   DOI
24 Ko, S. K., Kim, J. S., Choi, Y. E., Lee, S. J., Park, K. S. and Chung, S. H : Anti-diabetic effects of mixed water extract from ginseng radix rubra, acanthopanacis cortex, and cordyceps. Kor. J. Pharmacogn. 33(4), 337 (2002)
25 Sotaniemi, E. A., Haapakoski, E. and Rautio, A. : Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care. 18(10), 1373 (1995)   DOI   ScienceOn
26 Defronzo, R. A. : Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med. 131, 281 (1999)   DOI   ScienceOn
27 Joo, C. N., Yoon, S. H., Lee, H. S., Kim, Y. D., Lee, H. B. and Koo, J. H. : Study on the hypoglycemic action of ginseng saponin on streptozotocin induced diabetic rats (1). Korean J. Ginseng Sci. 16(3), 190 (1992)
28 Lee, S. J., Sung, J. H., Lee, S. J., Moon, C. K. and Lee, B. H. : Antitimor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett. 144, 39 (1999)   DOI   ScienceOn
29 Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. L. : Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412 (1985)   DOI   ScienceOn